<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">3 Biotech</journal-id><journal-id journal-id-type="iso-abbrev">3 Biotech</journal-id><journal-title-group><journal-title>3 Biotech</journal-title></journal-title-group><issn pub-type="ppub">2190-572X</issn><issn pub-type="epub">2190-5738</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28401457</article-id><article-id pub-id-type="pmc">5388652</article-id><article-id pub-id-type="publisher-id">595</article-id><article-id pub-id-type="doi">10.1007/s13205-016-0595-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Comparative studies of vertebrate iduronate 2-sulfatase (<italic>IDS</italic>) genes and proteins: evolution of A mammalian X-linked gene</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Holmes</surname><given-names>Roger S.</given-names></name><address><phone>+61 410583348</phone><email>r.holmes@griffith.edu.au</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0437 5432</institution-id><institution-id institution-id-type="GRID">grid.1022.1</institution-id><institution>Griffith Institute for Drug Discovery and School of Natural Sciences, </institution><institution>Griffith University, </institution></institution-wrap>Nathan, QLD 4111 Australia </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2017</year></pub-date><volume>7</volume><issue>1</issue><elocation-id>22</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">IDS is responsible for the lysosomal degradation of heparan sulfate and dermatan sulfate and linked to an X-linked lysosomal storage disease, mucopolysaccharidosis 2 (MPS2), resulting in neurological damage and early death. Comparative IDS amino acid sequences and structures and <italic>IDS</italic> gene locations were examined using data from several vertebrate genome projects. Vertebrate IDS sequences shared 60&#x02013;99% identities with each other. Human IDS showed 47% sequence identity with fruit fly (<italic>Drosophila melanogaster</italic>) IDS. Sequence alignments, key amino acid residues, <italic>N</italic>-glycosylation sites and conserved predicted secondary and tertiary structures were also studied, including signal peptide, propeptide and active site residues. Mammalian <italic>IDS</italic> genes usually contained 9 coding exons. The human <italic>IDS</italic> gene promoter contained a large CpG island (CpG46) and 5 transcription factor binding sites, whereas the 3&#x02032;-UTR region contained 5 miRNA target sites. These may contribute to <italic>IDS</italic> gene regulation of expression in the brain and other neural tissues of the body. An <italic>IDS</italic> pseudogene (<italic>IDSP1</italic>) was located proximally to the <italic>IDS</italic> gene on the X-chromosome in primate genomes. Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate <italic>IDS</italic> gene. These suggested that <italic>IDS</italic> has originated in an invertebrate ancestral genome and retained throughout vertebrate evolution and conserved on marsupial and eutherian X-chromosomes, with the exception of rat <italic>Ids</italic> on chromosome 8.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s13205-016-0595-3) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Vertebrates</kwd><kwd>Iduronate 2-sulfatase</kwd><kwd>Amino acid sequence</kwd><kwd>IDS</kwd><kwd>X-chromosome</kwd><kwd><italic>IDS</italic> gene regulation</kwd><kwd>Evolution</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; King Abdulaziz City for Science and Technology 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par14">Iduronate 2-sulfatase (IDS; EC 3.1.6.13) is responsible for the lysosomal degradation of the glycoaminoglycans, heparan sulfate and dermatan sulfate (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>), and is one of the 19 members of human sulfatase gene families and 17 members of the mouse sulfatase gene families which catalyze the hydrolysis of sulfate esters in the body derived from several catabolic pathways (Ratzka et al. <xref ref-type="bibr" rid="CR29">2010</xref>). Many <italic>IDS</italic> gene mutations and IDS deficiencies have been studied in human populations which result in the lysosomal storage of glycoaminoglycans and Hunter syndrome, an X-linked chromosome disease, referred to as mucopolysaccharidosis type 2 (MPS2) (Wilson et al. <xref ref-type="bibr" rid="CR42">1990</xref>; Rathmann et al. <xref ref-type="bibr" rid="CR28">1996</xref>; Chistiakov et al. <xref ref-type="bibr" rid="CR7">2014</xref>; Kosuga et al. <xref ref-type="bibr" rid="CR19">2016</xref>). Major clinical features for this rare genetic disease (1:100,000 births) include obstructive and restrictive airway disease, skeletal deformations, cardiac disease, joint contractures and mental retardation (Beck <xref ref-type="bibr" rid="CR2">2011</xref>; Tylki-Szyma&#x00144;ska <xref ref-type="bibr" rid="CR39">2014</xref>; Anekar et al. <xref ref-type="bibr" rid="CR1">2015</xref>). Mouse and zebra fish animal models have been used to study the disease in more detail, including studies of <italic>Ids</italic>
<sup><italic>&#x02212;</italic></sup>
<italic>/Ids</italic>
<sup><italic>&#x02212;</italic></sup> knock out mice which have shown that IDS-deficiency generates many of the defects reported for human MPS2 (Garcia et al. <xref ref-type="bibr" rid="CR13">2007</xref>). In addition, possible treatments for the disease by enzyme replacement therapy have been investigated (Garcia et al. <xref ref-type="bibr" rid="CR13">2007</xref>; Moro et al. <xref ref-type="bibr" rid="CR24">2010</xref>; Fusar Poli et al. <xref ref-type="bibr" rid="CR12">2013</xref>; Cho et al. <xref ref-type="bibr" rid="CR8">2015</xref>; Parini et al. <xref ref-type="bibr" rid="CR27">2015</xref>) and a phase I/II clinical trial of intrathecal IDS replacement therapy in children with severe MPS2 has been recently reported (Muenzer et al. <xref ref-type="bibr" rid="CR25">2016</xref>).</p><p id="Par15">The gene encoding IDS (<italic>IDS</italic> in primates; <italic>Ids</italic> in rodents) is expressed at high levels in neural tissues, particularly in the cortex, hippocampus, other brain and eye tissues; and is also widely expressed throughout the body (Smith et al. <xref ref-type="bibr" rid="CR37">2014</xref>). The enzyme catalyzes the first step in the degradation of glycoaminoglycans, dermatan sulfate and heparan sulfate (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>). Human <italic>IDS</italic> is expressed as three major isoforms which have distinct C-terminal sequences: <italic>IDSa</italic> encoding a 550 amino acid protein, expressed in brain tissues and with a wide tissue distribution; <italic>IDSb</italic>, 460 amino acids also expressed in brain tissues; and <italic>IDSc</italic>, encoding a 446 amino acid enzyme expressed in ductal carcinoma cells and pancreas (Thierry-Mieg and Thierry-Mieg <xref ref-type="bibr" rid="CR38">2006</xref>). The genomic organization of the human and mouse <italic>IDS</italic>/<italic>Ids</italic> genes have been reported with 9 exons observed for 24&#x000a0;kb and 22&#x000a0;kbs of DNA, respectively (Wilson et al. <xref ref-type="bibr" rid="CR43">1993</xref>; Thierry-Mieg and Thierry-Mieg <xref ref-type="bibr" rid="CR38">2006</xref>).</p><p id="Par16">Biochemical and predictive structural studies of human IDS have shown that it comprises several domains: an N-terminus signal peptide (residues 1&#x02013;25); a propeptide sequence (residues 26&#x02013;33); five Ca<sup>2+</sup> binding sites (1 Ca<sup>2+</sup> per subunit); two active site residues (334Asp and 335His); and seven N-glycosylation sites (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>; Wilson et al. <xref ref-type="bibr" rid="CR42">1990</xref>; Kosuga et al. <xref ref-type="bibr" rid="CR19">2016</xref>). A predicted tertiary structure has been reported for human IDS (S&#x000e1;enz et al. <xref ref-type="bibr" rid="CR31">2007</xref>), which shows strong similarities with other human sulfatases: GALNS (Rivera-Col&#x000f3;n et al. (<xref ref-type="bibr" rid="CR30">2012</xref>)); ARSA (Chruszcz et al. <xref ref-type="bibr" rid="CR9">2003</xref>) and STS (Hernandez-Guzman et al. <xref ref-type="bibr" rid="CR15">2003</xref>).</p><p id="Par17">This paper reports the predicted gene structures and amino acid sequences for several vertebrate <italic>IDS</italic> genes and proteins, the predicted structures for vertebrate IDS proteins, a number of potential sites for regulating human <italic>IDS</italic> gene expression and the structural, phylogenetic and evolutionary relationships for these genes and enzymes.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Vertebrate <italic>IDS</italic> gene and protein identification</title><p id="Par18">BLAST studies were undertaken using web tools from NCBI (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>) (Camacho et al. <xref ref-type="bibr" rid="CR6">2009</xref>). Protein BLAST analyses used human and mouse IDS amino acid sequences previously described (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>; Garcia et al. <xref ref-type="bibr" rid="CR13">2007</xref>) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Protein sequence databases for several vertebrate genomes were examined using the blastp algorithm (see Holmes <xref ref-type="bibr" rid="CR16">2016</xref>). Predicted IDS protein sequences were obtained in each case and subjected to analyses of predicted protein and gene structures.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Vertebrate IDS Proteins</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">ID<italic>S</italic> Protein</th><th align="left">Species</th><th align="left">UNIPROT ID</th><th align="left">Amino acids</th><th align="left">Subunit MW</th><th align="left">pI</th><th align="left">
<italic>N</italic>-Glycosylation sites</th><th align="left">Signal peptide</th><th align="left">% Identity human IDS</th></tr></thead><tbody><tr><td align="left">Human</td><td align="left">
<italic>Homo sapiens</italic>
</td><td align="left">P22304</td><td char="." align="char">550</td><td char="." align="char">61,873</td><td char="." align="char">5.2</td><td align="left">115, 144, 246, 280, 325, 513, 537</td><td align="left">1..25</td><td char="." align="char">100</td></tr><tr><td align="left">Chimpanzee</td><td align="left">
<italic>Pan troglodytes</italic>
</td><td align="left">na</td><td char="." align="char">550</td><td char="." align="char">61,861</td><td char="." align="char">5.2</td><td align="left">115, 144, 246, 280, 325, 513, 537</td><td align="left">1..25</td><td char="." align="char">99</td></tr><tr><td align="left">Orangutan</td><td align="left">
<italic>Pongo abelii</italic>
</td><td align="left">H2PX10</td><td char="." align="char">550</td><td char="." align="char">62,083</td><td char="." align="char">5.4</td><td align="left">115, 144, 246, 280, 325, 513, 537</td><td align="left">1..25</td><td char="." align="char">96</td></tr><tr><td align="left">Baboon</td><td align="left">
<italic>Papio anubis</italic>
</td><td align="left">na</td><td char="." align="char">550</td><td char="." align="char">61,885</td><td char="." align="char">5.1</td><td align="left">115, 144, 246, 280, 325, 513, 537</td><td align="left">1..25</td><td char="." align="char">96</td></tr><tr><td align="left">Marmoset</td><td align="left">
<italic>Callithrix jacchus</italic>
</td><td align="left">F7EJG2</td><td char="." align="char">550</td><td char="." align="char">61,812</td><td char="." align="char">5.4</td><td align="left">115, 144, 246, 280, 325, 513, 537</td><td align="left">1..25</td><td char="." align="char">94</td></tr><tr><td align="left">Mouse</td><td align="left">
<italic>Mus musculus</italic>
</td><td align="left">Q08890</td><td char="." align="char">552</td><td char="." align="char">62,186</td><td char="." align="char">5.5</td><td align="left">117, 146, 248, 282, 515, 539</td><td align="left">1..29</td><td char="." align="char">86</td></tr><tr><td align="left">Rat</td><td align="left">
<italic>Rattus norvegicus</italic>
</td><td align="left">Q32KJ4</td><td char="." align="char">543</td><td char="." align="char">62,370</td><td char="." align="char">5.5</td><td align="left">117, 146, 248, 181, 515, 539</td><td align="left">1..20</td><td char="." align="char">85</td></tr><tr><td align="left">Cow</td><td align="left">
<italic>Bos taurus</italic>
</td><td align="left">F1N2D5</td><td char="." align="char">547</td><td char="." align="char">61,389</td><td char="." align="char">5.8</td><td align="left">112, 141, 243, 277, 509, 533</td><td align="left">1..20</td><td char="." align="char">82</td></tr><tr><td align="left">Sheep</td><td align="left">
<italic>Ovis aries</italic>
</td><td align="left">W5PI67</td><td char="." align="char">547</td><td char="." align="char">61,019</td><td char="." align="char">5.6</td><td align="left">112, 141, 243, 277, 510, 534</td><td align="left">1..20</td><td char="." align="char">82</td></tr><tr><td align="left">Opossum</td><td align="left">
<italic>Monodelphis domestica</italic>
</td><td align="left">F7DJA1</td><td char="." align="char">558</td><td char="." align="char">63,374</td><td char="." align="char">5.3</td><td align="left">129, 260, 294, 339, 457, 524, 552</td><td align="left">1..23</td><td char="." align="char">75</td></tr><tr><td align="left">Tasmanian devil</td><td align="left">
<italic>Sarcophilus harrisii</italic>
</td><td align="left">na</td><td char="." align="char">539</td><td char="." align="char">61,392</td><td char="." align="char">5.3</td><td align="left">111, 140, 242, 276, 321, 505, 509, 533</td><td align="left">1..22</td><td char="." align="char">74</td></tr><tr><td align="left">Chicken</td><td align="left">
<italic>Gallus gallus</italic>
</td><td align="left">F1NFI0</td><td char="." align="char">601</td><td char="." align="char">68,047</td><td char="." align="char">6.6</td><td align="left">156, 185, 287, 321, 366, 584</td><td align="left">na</td><td char="." align="char">67</td></tr><tr><td align="left">Lizard</td><td align="left">
<italic>Anolis carolinensis</italic>
</td><td align="left">H9GGQ8</td><td char="." align="char">524</td><td char="." align="char">59,239</td><td char="." align="char">5.8</td><td align="left">92, 121, 223, 257, 478, 507</td><td align="left">na</td><td char="." align="char">63</td></tr><tr><td align="left">Frog</td><td align="left">
<italic>Xenopus tropicalis</italic>
</td><td align="left">A8WGX6</td><td char="." align="char">542</td><td char="." align="char">61,858</td><td char="." align="char">6.1</td><td align="left">112, 141, 243, 277, 322</td><td align="left">1..18</td><td char="." align="char">66</td></tr><tr><td align="left">Zebra fish</td><td align="left">
<italic>Danio rerio</italic>
</td><td align="left">A1A5V0</td><td char="." align="char">561</td><td char="." align="char">63,771</td><td char="." align="char">7.7</td><td align="left">109, 138, 181, 240, 274, 499</td><td align="left">1..25</td><td char="." align="char">60</td></tr><tr><td align="left">Fruit Fly</td><td align="left">
<italic>Drosophila melanogaster</italic>
</td><td align="left">na</td><td char="." align="char">502</td><td char="." align="char">57,760</td><td char="." align="char">7.3</td><td char="." align="char">93, 12, 22, 22, 22, 82, 60, 400</td><td align="left">na</td><td char="." align="char">47</td></tr></tbody></table><table-wrap-foot><p>UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual IDS proteins (see <ext-link ext-link-type="uri" xlink:href="http://kr.expasy.org">http://kr.expasy.org</ext-link>); pI refers to theoretical isoelectric points</p></table-wrap-foot></table-wrap>
</p><p id="Par19">BLAT analyses were subsequently undertaken for each of the predicted IDS amino acid sequences using the UC Santa Cruz (UCSC) Genome Browser with the default settings to obtain the predicted locations for each of the vertebrate <italic>IDS</italic> genes, including predicted exon boundary locations and gene sizes (Kent et al. <xref ref-type="bibr" rid="CR18">2002</xref>). BLAT analyses were similarly undertaken for other vertebrate <italic>IDS</italic> genes using previously reported sequences in each case (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Structures for human isoforms (splicing variants) were obtained using the AceView website to examine predicted gene and protein structures (Thierry-Mieg and Thierry-Mieg <xref ref-type="bibr" rid="CR38">2006</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Vertebrate IDS Genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">
<italic>IDS</italic> Gene</th><th align="left">Species</th><th align="left">RefSeq ID</th><th align="left">GenBank ID</th><th align="left">Chromosome location</th><th align="left">Coding exons (strand)</th><th align="left">Gene size (bps)</th></tr></thead><tbody><tr><td align="left">Human</td><td align="left">
<italic>Homo sapiens</italic>
</td><td align="left">NM_000202</td><td align="left">BC006170</td><td align="left">X:149,482,749&#x02013;149,505,137</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">22,389</td></tr><tr><td align="left">
<italic>IDSP1</italic>
</td><td align="left">
<italic>Homo sapiens</italic>
</td><td align="left">na</td><td align="left">na</td><td align="left">X:149,525,002&#x02013;149,525,923</td><td align="left">na</td><td char="." align="char">922</td></tr><tr><td align="left">Chimpanzee</td><td align="left">
<italic>Pan troglodytes</italic>
</td><td align="left">XP_016799854</td><td align="left">na</td><td align="left">X:150,217,197&#x02013;150,239,595</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">22,399</td></tr><tr><td align="left">Orangutan</td><td align="left">
<italic>Pongo abelii</italic>
</td><td align="left">XP_002832265</td><td align="left">na</td><td align="left">X:149,468,629&#x02013;149,491,886</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">23,258</td></tr><tr><td align="left">Baboon</td><td align="left">
<italic>Papio anubis</italic>
</td><td align="left">XP_003918436</td><td align="left">na</td><td align="left">X:137,241,259&#x02013;137,263,520</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">22,262</td></tr><tr><td align="left">Marmoset</td><td align="left">
<italic>Callithrix jacchus</italic>
</td><td align="left">XP_002763402</td><td align="left">na</td><td align="left">X:136,661,096&#x02013;136,690,421</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">29,326</td></tr><tr><td align="left">Mouse</td><td align="left">
<italic>Mus musculus</italic>
</td><td align="left">NM_010498</td><td align="left">BN000750</td><td align="left">X:70,346,204&#x02013;70,364,903</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">18,700</td></tr><tr><td align="left">Rat</td><td align="left">
<italic>Rattus norvegicus</italic>
</td><td align="left">XP_017451660</td><td align="left">BN000743</td><td align="left">
<bold>8</bold>:69,158,393&#x02013;69,174,447</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">16,055</td></tr><tr><td align="left">Cow</td><td align="left">
<italic>Bos taurus</italic>
</td><td align="left">NM_001192851</td><td align="left">na</td><td align="left">X:32,309,006&#x02013;32,324,359</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">15,354</td></tr><tr><td align="left">Sheep</td><td align="left">
<italic>Ovis aries</italic>
</td><td align="left">XP_012016345</td><td align="left">na</td><td align="left">X:81,295,118&#x02013;81,310,976</td><td align="left">9 (+ve)</td><td char="." align="char">15,859</td></tr><tr><td align="left">Opossum</td><td align="left">
<italic>Monodelphis domestica</italic>
</td><td align="left">XP_007507328</td><td align="left">na</td><td align="left">X:38,769,936&#x02013;38,797,831</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">27,896</td></tr><tr><td align="left">Tasmanian devil</td><td align="left">
<italic>Sarcophilus harrisii</italic>
</td><td align="left">XP_012408735</td><td align="left">na</td><td align="left">X_GL867598:1,290,327&#x02013;1,307,074</td><td align="left">9 (&#x02212;ve)</td><td char="." align="char">16,748</td></tr><tr><td align="left">Chicken</td><td align="left">
<italic>Gallus gallus</italic>
</td><td align="left">XP_015133789</td><td align="left">na</td><td align="left">4:18,031,638&#x02013;18,046,283</td><td align="left">9 (+ve)</td><td char="." align="char">14,646</td></tr><tr><td align="left">Lizard</td><td align="left">
<italic>Anolis carolinensis</italic>
</td><td align="left">XP_016851828</td><td align="left">na</td><td align="left">GL343310:1,066,926&#x02013;1,092,995</td><td align="left">8 (+ve)</td><td char="." align="char">26,070</td></tr><tr><td align="left">Frog</td><td align="left">
<italic>Xenopus tropicalis</italic>
</td><td align="left">NM_001197132</td><td align="left">BC154891</td><td align="left">KB021658:33,136,298&#x02013;33,145,211</td><td align="left">9 (+ve)</td><td char="." align="char">8914</td></tr><tr><td align="left">Zebra fish</td><td align="left">
<italic>Danio rerio</italic>
</td><td align="left">NM_001080068</td><td align="left">BC128823</td><td align="left">14:20,572,602&#x02013;20,594,434</td><td align="left">8 (&#x02212;ve)</td><td char="." align="char">21,833</td></tr><tr><td align="left">Fruit Fly</td><td align="left">
<italic>Drosophila melanogaster</italic>
</td><td align="left">NM_139557</td><td align="left">AAY55004</td><td align="left">3L:3,378,315&#x02013;3,380,000</td><td align="left">4 (+ve)</td><td char="." align="char">1686</td></tr></tbody></table><table-wrap-foot><p>GenBank IDs are derived from NCBI <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/genbank/">http://www.ncbi.nlm.nih.gov/genbank/</ext-link>; GL and KB refer to a scaffold; bps refers to base pairs of nucleotide sequences; the number of coding exons are listed</p><p>
<italic>RefSeq</italic> The reference sequence, <italic>XP</italic> predicted sequence, <italic>na</italic> not available</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec4"><title>Predicted structures and properties of vertebrate IDS</title><p id="Par20">Predicted secondary and tertiary structures for vertebrate IDS proteins were obtained using the SWISS-MODEL web-server (<ext-link ext-link-type="uri" xlink:href="http://swissmodel.expasy.org/">http://swissmodel.expasy.org/</ext-link>) (Schwede et al. <xref ref-type="bibr" rid="CR34">2003</xref>) using the reported tertiary structure for human arylsulfatase A (ARSA) (Lukatela et al. <xref ref-type="bibr" rid="CR21">1998</xref>; Chrusczcs et al. <xref ref-type="bibr" rid="CR9">2003</xref>) (PDB:1n2kA) with a modeling range of 35&#x02013;549 for human IDS. Molecular weights, <italic>N</italic>-glycosylation sites and signal peptide cleavage sites for vertebrate IDS proteins were obtained using Expasy web tools (<ext-link ext-link-type="uri" xlink:href="http://au.expasy.org/tools/pi_tool.html">http://au.expasy.org/tools/pi_tool.html</ext-link>). The identification of conserved domains for IDS was conducted using NCBI web tools (Marchler-Bauer et al. <xref ref-type="bibr" rid="CR22">2011</xref>).</p></sec></sec><sec id="Sec5"><title>Human <italic>IDS</italic> tissue expression</title><p id="Par21">RNA-seq gene expression profiles across 53 selected tissues (or tissue segments) were examined from the public database for human <italic>IDS</italic>, based on expression levels for 175 individuals (GTEx Consortium <xref ref-type="bibr" rid="CR14">2015</xref>) (Data Source: GTEx Analysis Release V6p (dbGaP Accession phs000424.v6.p1) (<ext-link ext-link-type="uri" xlink:href="http://www.gtex.org">http://www.gtex.org</ext-link>).</p></sec><sec id="Sec6"><title>Amino acid sequence alignments and phylogenetic analyses</title><p id="Par22">Alignments of vertebrate and <italic>Drosophila melanogaster</italic> IDS sequences were undertaken using Clustal Omega, a multiple sequence alignment program (Sievers and Higgins <xref ref-type="bibr" rid="CR36">2014</xref>) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Percentage identities were derived from the results of these alignments (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Phylogenetic analyses used several bioinformatic programs, coordinated using the <ext-link ext-link-type="uri" xlink:href="http://www.phylogeny.fr/">http://www.phylogeny.fr/</ext-link> bioinformatic portal, to enable alignment (MUSCLE), curation (Gblocks), phylogeny (PhyML) and tree rendering (TreeDyn), to reconstruct phylogenetic relationships (Dereeper et al. <xref ref-type="bibr" rid="CR11">2008</xref>). Sequences were identified as vertebrate IDS members and a proposed primordial <italic>Drosophila melanogaster IDS</italic> gene and protein (Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref>).</p></sec><sec id="Sec7"><title>Results and discussion</title><sec id="Sec8"><title>Alignments of vertebrate IDS amino acid sequences</title><p id="Par23">The deduced amino acid sequences for frog (<italic>Xenopus tropicalis</italic>) and zebrafish (<italic>Danio rerio</italic>) IDS are shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> together with previously reported sequences for human (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>) and mouse IDS (Garcia et al. <xref ref-type="bibr" rid="CR13">2007</xref>) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Alignments of human with other vertebrate IDS sequences examined were between 60 and 99% identical, suggesting that these are products of the same family of genes, whereas comparisons of sequence identities of vertebrate IDS proteins with other human ARS proteins exhibited &#x02265;27% identities, indicating that these are members of distinct <italic>ARS</italic>-like gene families (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>; Supplementary Table&#x000a0;1).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Amino acid sequence alignments for vertebrate IDS sequences. See Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> for sources of IDS sequences; <italic>asterisk</italic> shows identical residues for IDS subunits; <italic>colon</italic> similar alternate residues; <italic>dot</italic> dissimilar alternate residues; predicted phosphoresidues are in <italic>pink</italic>; predicted <italic>N</italic>-glycosylated Asn sites are in <italic>green</italic>; the active site residues (for human IDS) are shown in <italic>blue</italic>; active site residue subject to modification is shown as <bold>A</bold>; predicted <italic>&#x003b1;</italic>-helices for human IDS is in<italic> shaded yellow</italic> and numbered in sequence; predicted <italic>&#x003b2;</italic>-sheets are in <italic>shaded gray</italic> and also numbered in sequence from the <italic>N</italic>-terminus; <italic>bold underlined font</italic> shows residues corresponding to known or predicted exon start sites; exon numbers refer to human <italic>IDS</italic> gene exons; leader peptide is in <italic>brown</italic>; propeptide in <italic>red</italic>
</p></caption><graphic xlink:href="13205_2016_595_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par24">The amino acid sequences for vertebrate IDS proteins contained 550&#x02013;561 amino acids (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>; Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Previous studies have reported several key regions and residues for human and mouse IDS proteins (human IDS amino acid residues were identified in each case) (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>). These included an N-terminus leader peptide (24 residues excluding the <italic>N</italic>-terminus methionine) followed by a propeptide 8-residue segment (residues 25&#x02013;33) (Wilson et al. <xref ref-type="bibr" rid="CR42">1990</xref>). A comparison of 10 mammalian IDS sequences for these <italic>N</italic>-terminal exon 1 regions revealed species specific variability in these sequences, with the signal peptides containing multiple proline and hydrophobic residues, and the propeptides exhibiting distinct mammalian sequences (see Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>). In contrast, amino acid sequences located further upstream within exon 2, nearer to the active site catalytic residues (Asp45; Asp46), were predominantly invariant among the mammalian and other vertebrate sequences examined (Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>). One of the conserved active site residues observed for these mammalian and other vertebrate IDS sequences, included an active site catalytic residue (Cys84) which undergoes post-translational modification by sulfatase modifying factor 1 (SUMF1) to form C(alpha)-formylglycine (Fgly), required at the active site of many sulfatases (Sardiello et al. <xref ref-type="bibr" rid="CR32">2005</xref>). Other invariant active site residues included 334Asp/335His, which are likely to be involved in Ca<sup>2+</sup> binding, based on predictions derived from 3D structures from other human sulfatases (Bond et al. <xref ref-type="bibr" rid="CR5">1997</xref>; Hernandez-Guzman et al. <xref ref-type="bibr" rid="CR15">2003</xref>). An internal proteolytic cleavage has been proposed for this enzyme as a result of the presence of 42- and 14-kD polypeptides in enzyme preparations derived from human liver, kidney, lung and placenta extracts (Wilson et al. <xref ref-type="bibr" rid="CR42">1990</xref>) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). It should be noted that the 42kD polypeptide contains the N-terminal sequence with all of the active site regions, whereas the 14kD polypeptide contained the catalytically inactive C-terminus region of human IDS.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Amino acid sequence alignments for mammalian IDS <italic>N</italic>-terminus sequences. See Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> for sources of IDS sequences; <italic>asterisk</italic> shows identical residues for IDS subunits; <italic>colon</italic> similar alternate residues; <italic>dot</italic> dissimilar alternate residues; the active site residues (for human IDS) are shown in <italic>blue</italic>; leader peptide is in <italic>brown</italic>; propeptide in <italic>red</italic>; <italic>bold underlined font</italic> shows residues corresponding to known or predicted exon start sites; exon numbers refer to human <italic>IDS</italic> gene exons</p></caption><graphic xlink:href="13205_2016_595_Fig2_HTML" id="MO2"/></fig>
</p><p id="Par25">Five <italic>N</italic>-glycosylation sites were consistently found for vertebrate IDS sequences (human IDS amino acid sequences identified in each case): Asn115-Phe116-Ser117 (site 1); Asn144-His145-Thr173 (site 2); Asn246-Ile247-Thr248 (site 3); Asn280-Ile281-Ser282 (site 4); and Asn513-Phe514-Ser515 (site 5). Two other N-glycosylation sites were observed for human IDS which were not commonly shared with other vertebrate IDS sequences, including Asn325-Ser326-Ser327 (site 6) and Asn537-Asp538-Ser539 (site 7), the latter restricted to mammalian IDS sequences (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>; Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Mutation analysis of the human <italic>IDS</italic> gene has shown that amino acid substitution of Asn115 (Asn&#x02192;Tyr) (for site 1) resulted in Hunter&#x02019;s disease, reflecting the key role of this N-glycosylation site in supporting the structure of this enzyme (Vafiadaki et al. <xref ref-type="bibr" rid="CR40">1998</xref>). Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> also shows predicted phosphosites sites that may contribute to regulating downstream cellular processes, molecular functions and protein&#x02013;protein interactions (Hornbeck et al. <xref ref-type="bibr" rid="CR17">2015</xref>). Five of these were strictly conserved among the vertebrate IDS sequences examined (human IDS residues: Ser282; Try285; Thr409; Tyr490; and Tyr497) supporting a role for these residues, as yet unknown.</p></sec><sec id="Sec9"><title>Predicted secondary and tertiary structures for vertebrate IDS</title><p id="Par26">A predicted secondary structure for the human IDS sequence was examined (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) using the known structure reported for human ARSA (Lukatela et al. <xref ref-type="bibr" rid="CR21">1998</xref>). Ten predicted &#x003b1;-helix and 21 &#x003b2;-sheet structures were observed for human IDS. Of particular interest were &#x003b2;-sheet structures (&#x003b2;1 and &#x003b2;11) and &#x003b1;-helix (&#x003b1;2) which were located proximate to the predicted active site residues for human IDS. The C-terminal end of human IDS contained a sequence of &#x003b2;-sheet structures (&#x003b2;15&#x02013;&#x003b2;21), in addition to the &#x003b1;-helix (&#x003b1;10) located at the C-terminus. A predicted tertiary structure for human IDS is shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. Two major domains for this enzyme were observed, that enclose a large cavity previously shown to contain the enzyme&#x02019;s active site. The more N-terminal of these domains contained the active site residues and comprised the bulk of the 42kD polypeptide chain previously reported (Wilson et al. <xref ref-type="bibr" rid="CR42">1990</xref>), whereas the other domain comprised most of the 14kD polypeptide, including the &#x003b2;-sheet structures (&#x003b2;15&#x02013;&#x003b2;21) and the C-terminal &#x003b1;-helix (&#x003b1;10).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Predicted tertiary structure for human IDS. The predicted structure for human IDS is based on the reported structure for human ARSA (Chrusczcz et al. <xref ref-type="bibr" rid="CR9">2003</xref>) and obtained using the SWISS MODEL web site based on PDB 1N2KA <ext-link ext-link-type="uri" xlink:href="http://swissmodel.expasy.org/workspace/">http://swissmodel.expasy.org/workspace/</ext-link>. The <italic>rainbow color</italic> code describes the 3-D structures from the <italic>N</italic>- (<italic>blue</italic>) to C-termini (<italic>red color</italic>) for residues 35&#x02013;549 for human IDS; predicted <italic>&#x003b1;</italic>-helices, <italic>&#x003b2;</italic>-sheets, proposed active site cleft, and <italic>N</italic>- and C-termini are shown</p></caption><graphic xlink:href="13205_2016_595_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec10"><title>Comparative human <italic>IDS</italic> tissue expression</title><p id="Par27">Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> shows comparative gene expression for various human tissues obtained from RNA-seq gene expression profiles for the human <italic>IDS</italic> gene obtained for 53 selected tissues or tissue segments for 175 individuals (GTEx Consortium <xref ref-type="bibr" rid="CR14">2015</xref>) (Data Source: GTEx Analysis Release V6p (dbGaP Accession phs000424.v6.p1) (<ext-link ext-link-type="uri" xlink:href="http://www.gtex.org">http://www.gtex.org</ext-link>). These data supported high levels of gene expression for human <italic>IDS</italic> in regions of the brain, particularly within the cortex, amygdala, hippocampus, hypothalamus and basal ganglia, but with lower levels in the brain cerebellum and spinal cord. IDS activity was also widely distributed at low levels among all other tissues examined. It is readily apparent that <italic>IDS</italic> is predominantly expressed in brain and nerve tissues of the body, which may reflect a specific role for IDS in neural glycoaminoglycan (GAG) metabolism, involving the efficient clearance of GAG sulfate residues within the extracellular matrix of nervous tissue.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Tissue expression for human IDS. RNA-seq gene expression profiles across 53 selected tissues (or tissue segments) were examined from the public database for human <italic>IDS</italic>, based on expression levels for 175 individuals (Data Source: GTEx Analysis Release V6p (dbGaP Accession phs000424.v6.p1) (<ext-link ext-link-type="uri" xlink:href="http://www.gtex.org">http://www.gtex.org</ext-link>). Tissues: <italic>1</italic>. Adipose-Subcutaneous; <italic>2</italic>. Adipose-Visceral (Omentum); <italic>3</italic>. Adrenal gland; <italic>4</italic>. Artery-Aorta; <italic>5</italic>. Artery-Coronary; <italic>6</italic>. Artery-Tibial; <italic>7</italic>. Bladder; <italic>8</italic>. Brain-Amygdala; <italic>9</italic>. Brain-Anterior cingulate Cortex (BA24); <italic>10</italic>. Brain-Caudate (basal ganglia); <italic>11</italic>. Brain-Cerebellar Hemisphere; <italic>12</italic>. Brain-Cerebellum; <italic>13</italic>. Brain-Cortex; <italic>14</italic>. Brain-Frontal Cortex; <italic>15</italic>. Brain-Hippocampus; <italic>16</italic>. Brain-Hypothalamus; <italic>17</italic>. Brain-Nucleus accumbens (basal ganglia); <italic>18</italic>. Brain-Putamen (basal ganglia); <italic>19</italic>. Brain-Spinal Cord (cervical c-1); <italic>20</italic>. Brain-Substantia nigra; <italic>21</italic>. Breast-Mammary Tissue; <italic>22</italic>. Cells-EBV-transformed lymphocytes; <italic>23</italic>. Cells-Transformed fibroblasts; <italic>24</italic>. Cervix-Ectocervix; <italic>25</italic>. Cervix-Endocervix; <italic>26</italic>. Colon-Sigmoid; <italic>27</italic>. Colon-Transverse; <italic>28</italic>. Esophagus-Gastroesophageal Junction; <italic>29</italic>. Esophagus- Mucosa; <italic>30</italic>. Esophagus-Muscularis; <italic>31</italic>. Fallopian Tube; <italic>32</italic>. Heart-Atrial Appendage; <italic>33</italic>. Heart-Left Ventricle; <italic>34</italic>. Kidney-Cortex; <italic>35</italic>. Liver; <italic>36</italic>. Lung; <italic>37</italic>. Minor Salivary Gland; <italic>38</italic>. Muscle-Skeletal; <italic>39</italic>. Nerve-Tibial; <italic>40</italic>. Ovary; <italic>41</italic>. Pancreas; <italic>42</italic>. Pituitary; <italic>43</italic>. Prostate; <italic>44</italic>. Skin-Not Sun Exposed (Suprapubic); <italic>45</italic>. Skin-Sun Exposed (Lower leg); <italic>46</italic>. Small Intestine-Terminal Ileum; <italic>47</italic>. Spleen; <italic>48</italic>. Stomach; <italic>49</italic>. Testis; <italic>50</italic>. Thyroid; <italic>51</italic>. Uterus; <italic>52</italic>. Vagina; <italic>53</italic>. Whole Blood</p></caption><graphic xlink:href="13205_2016_595_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec11"><title>Gene locations, exonic structures and regulatory sequences for vertebrate <italic>IDS</italic> genes</title><p id="Par28">Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> summarizes the predicted locations for vertebrate and fruit fly (<italic>Drosophila melanogaster</italic>) <italic>IDS</italic> genes based upon BLAT interrogations of several genomes using the reported sequence for human IDS (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>; Wilson et al. <xref ref-type="bibr" rid="CR42">1990</xref>) and the predicted sequences for other IDS enzymes and the UCSC genome browser (Kent et al. (<xref ref-type="bibr" rid="CR18">2002</xref>)). The predicted vertebrate <italic>IDS</italic> genes were transcribed on both the negative strand (primates, mouse, rat, cow, marsupial and zebra fish genomes) and the positive strand (sheep, chicken, lizard and frog genomes). Of particular interest is the X-chromosome location for <italic>IDS</italic> for all eutherian and marsupial mammals examined with the exception of rat <italic>Ids</italic> gene, which is located on an autosome (chromosome 8). This is indicative of a chromosomal transfer between the common ancestral X-chromosome and chromosome 8 during rat evolution. An <italic>IDS</italic> pseudogene (designated as <italic>IDSP1</italic>) was also observed for human and other primate genomes. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> summarizes the predicted exonic start sites for human, mouse, frog and zebra fish <italic>IDS</italic> genes with each having 9 coding exons, in identical or similar positions to those predicted for the human <italic>IDS</italic> gene. In each case, exon 1 encoded the leader peptide and propeptide with exons 2, 3 and 7 encoding the predicted active site regions for this enzyme.</p><p id="Par29">Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> shows the predicted structures for the three major human <italic>IDS</italic> transcripts (<italic>IDSa</italic>; <italic>IDSb</italic>; and <italic>IDSc</italic>) together with CpG46 and several transcription factor binding sites (TFBS), which are located at the 5&#x02032; end of the gene, consistent with roles in regulating the transcription of this gene and forming part of the <italic>IDS</italic> gene promoter. The human <italic>IDSa</italic> transcript was 6088&#x000a0;bps in length with an extended 3&#x02032;-untranslated region (UTR) containing 5 microRNA target sites; the human <italic>IDSb</italic> transcript was 5808 bps in length, also containing 5 microRNA target sites; whereas the <italic>IDSc</italic> transcript was much shorter in length (2213&#x000a0;bps), comprising only 8 coding exons and with no microRNA target sites present. The presence of miR-200 within the 3&#x02032;-UTR of the human <italic>IDS</italic> gene was of special interest due to this miR family being induced and having a specific role during the late stages of neuronal differentiation (Beclin et al. <xref ref-type="bibr" rid="CR3">2016</xref>). In addition, the presence of miR-7 in this region may also be significant given that miR-7 inhibits neuronal apoptosis in a cellular Parkinson&#x02019;s disease model (Li et al. <xref ref-type="bibr" rid="CR20">2016</xref>) and contributes to the alteration of neuronal morphology and function (Zhang et al. <xref ref-type="bibr" rid="CR44">2015</xref>). Moreover, miR-203 has a proposed role as a stemness inhibitor of glioblastoma stem cells and may contribute to the increased expression of glial and neuronal differentiation markers (Deng et al. <xref ref-type="bibr" rid="CR10">2016</xref>).<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Gene structure and major gene transcripts for the human IDS gene. Derived from the AceView website <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/">http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/</ext-link> (Thierry-Mieg and Thierry-Mieg <xref ref-type="bibr" rid="CR38">2006</xref>); shown with capped 5&#x02032;- and 3&#x02032;- ends for the predicted mRNA sequences; NM refers to the NCBI reference sequence; coding exons are in pink; the direction for transcription is shown as 5&#x02032; &#x02192; 3&#x02032;; a large CpG46 island at the gene promoter is shown (see Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> for details of CpG islands for human and other vertebrate <italic>IDS</italic> gene promoters); 5 predicted transcription factor binding sites (TFBS) for human <italic>IDS</italic> are shown (see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>s for details); 5 predicted miRNA target sites were identified within the extended 3&#x02032;-UTR region of human <italic>IDS</italic>a and <italic>IDSb</italic> transcripts</p></caption><graphic xlink:href="13205_2016_595_Fig5_HTML" id="MO5"/></fig>
</p><p id="Par30">The human <italic>IDS</italic> genome sequence also contained several predicted transcription factor binding sites (TFBS) and a large CpG island (CpG46) located in the 5&#x02032;-untranslated promoter region of human <italic>IDS</italic> on the X-chromosome. CpG46 contained 432 bps with a C plus G count of 279 bps, a C or G content of 65% and showed a ratio of observed to expected CpG of 1.02. Similar CpG islands were observed in the <italic>IDS</italic> gene promoters for other primate, eutherian mammal, marsupial (opossum) and bird (chicken) genomes (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). It is likely therefore that these <italic>IDS</italic> CpG islands play a key role in regulating this gene and may contribute to the very high level of gene expression observed in neural tissues (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>) (Saxanov et al. <xref ref-type="bibr" rid="CR33">2006</xref>). At least 5 TFBS sites were colocated with CpG46 in the human <italic>IDS</italic> promoter region which may contribute to the high expression of this gene in human nerve and brain tissues (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Of special interest among these transcription factor binding sites were the following: <italic>BACH1</italic> and <italic>BACH2</italic> have been recognized as members of the BTB-basic region leucine zipper transcription factor family which downregulate cell proliferation of neuroblastoma cells (Shim et al. <xref ref-type="bibr" rid="CR35">2006</xref>); <italic>AP1</italic> is constitutively upregulated in activated microglia and during the pathogenesis of Parkinson&#x02019;s disease (Pal et al. <xref ref-type="bibr" rid="CR26">2016</xref>); <italic>NFE2</italic> has been shown to participate in the developmental regulation of the brain in zebrafish embryos (Williams et al. <xref ref-type="bibr" rid="CR41">2013</xref>); and <italic>XBP1</italic> has been identified as a risk factor for Alzheimer&#x02019;s disease and bipolar disorders, contributing to impairment of contextual memory formation (Martinez et al. <xref ref-type="bibr" rid="CR23">2016</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Vertebrate <italic>IDS</italic> CpG Islands</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Vertebrate</th><th align="left">CpG Island ID</th><th align="left">Chromosomal position</th><th align="left">CpG size</th><th align="left">C count plus G count</th><th align="left">% C or G</th><th align="left">Ratio of observed to expected CpG</th></tr></thead><tbody><tr><td align="left">Human</td><td align="left">CpG 46</td><td align="left">ChrX:148,586,553&#x02013;148,586,984</td><td char="." align="char">432</td><td char="." align="char">279</td><td char="." align="char">65</td><td char="." align="char">1.02</td></tr><tr><td align="left">Baboon</td><td align="left">CpG 50</td><td align="left">ChrX:137,263,406&#x02013;137,263,837</td><td char="." align="char">432</td><td char="." align="char">306</td><td char="." align="char">71</td><td char="." align="char">.92</td></tr><tr><td align="left">Rhesus</td><td align="left">CpG53</td><td align="left">ChrX:143,222,778&#x02013;143,223,221</td><td char="." align="char">444</td><td char="." align="char">318</td><td char="." align="char">72</td><td char="." align="char">.93</td></tr><tr><td align="left">Mouse</td><td align="left">CpG 26</td><td align="left">ChrX:70,364,872&#x02013;70,365,161</td><td char="." align="char">290</td><td char="." align="char">159</td><td char="." align="char">55</td><td char="." align="char">1.2</td></tr><tr><td align="left">Rat</td><td align="left">CpG 26</td><td align="left">Chr8:69,175,527&#x02013;69,175,735</td><td char="." align="char">209</td><td char="." align="char">138</td><td char="." align="char">66</td><td char="." align="char">1.14</td></tr><tr><td align="left">Cow</td><td align="left">CpG 53</td><td align="left">ChrX:32,324,232&#x02013;32,324,656</td><td char="." align="char">425</td><td char="." align="char">317</td><td char="." align="char">75</td><td char="." align="char">.9</td></tr><tr><td align="left">Dog</td><td align="left">CpG 51</td><td align="left">ChrX;117,515,293&#x02013;117,515,743</td><td char="." align="char">451</td><td char="." align="char">293</td><td char="." align="char">65</td><td char="." align="char">1.1</td></tr><tr><td align="left">Opossum</td><td align="left">CpG2 29</td><td align="left">ChrX:38,797,675&#x02013;38,797,993</td><td char="." align="char">319</td><td char="." align="char">189</td><td char="." align="char">59</td><td char="." align="char">1.05</td></tr><tr><td align="left">Chicken</td><td align="left">CpG 54</td><td align="left">Chr4:18,031,448&#x02013;18,032,009</td><td char="." align="char">562</td><td char="." align="char">333</td><td char="." align="char">59</td><td char="." align="char">1.09</td></tr></tbody></table><table-wrap-foot><p>The identification of <italic>IDS</italic> CpG islands, sequences and properties was undertaken using various vertebrate genome browsers (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>)</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Identification of transcription factor binding sites (TFBS) within the human <italic>IDS</italic> gene promoter</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">TFBS</th><th align="left">Strand</th><th align="left">Chr 1 Position</th><th align="left">Function/role</th><th align="left">Sequence</th><th align="left">UNIPROT ID</th></tr></thead><tbody><tr><td align="left">BACH2</td><td align="left">(+ve)</td><td align="left">X:148,585,129&#x02013;139</td><td align="left">Binds to Maf recognition elemants</td><td align="left">
<preformat>GCTGAGTCATG</preformat>
</td><td align="left">Q9BYV9</td></tr><tr><td align="left">AP1</td><td align="left">(&#x02212;ve)</td><td align="left">X:148,585,128&#x02013;140</td><td align="left">Regulating cells forming the skeleton</td><td align="left">
<preformat>GCATGACTCAGCT</preformat>
</td><td align="left">P01101</td></tr><tr><td align="left">NFE2</td><td align="left">(+ve)</td><td align="left">X:148,585,128&#x02013;138</td><td align="left">Regulating erythroid maturation</td><td align="left">AGCTGAGTCAT</td><td align="left">Q16621</td></tr><tr><td align="left">BACH1</td><td align="left">(+ve)</td><td align="left">X:148,585,127&#x02013;141</td><td align="left">Coordinates transcription by MAFK</td><td align="left">TAGCTGAGTCATGCA</td><td align="left">O14867</td></tr><tr><td align="left">XBP1</td><td align="left">(+ve)</td><td align="left">X:148,584,868&#x02013;884</td><td align="left">Regulation during ER stress</td><td align="left">ATGGTCACATAGCCATT</td><td align="left">P17861</td></tr></tbody></table><table-wrap-foot><p>The identification of TFBS within the <italic>IDS</italic> promoter region was undertaken using the human genome browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>); UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual TFBS sequences (see <ext-link ext-link-type="uri" xlink:href="http://kr.expasy.org">http://kr.expasy.org</ext-link>); <italic>ER</italic> refers to endoplasmic reticulum</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec12"><title>Phylogeny and divergence of vertebrate IDS</title><p id="Par31">A phylogenetic tree (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>) was calculated by the progressive alignment of 15 vertebrate IDS amino acid sequences with several other human ARS-like sequences (see Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The IDS phylogram was &#x02018;rooted&#x02019; with the fruit fly (<italic>Drosophila melanogaster</italic>) IDS sequence (see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The phylogram showed clustering of the IDS sequences into a single group which is represented throughout vertebrate evolution and has apparently evolved from an invertebrate <italic>IDS</italic> gene ancestor.<fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Phylogenetic tree of vertebrate IDS amino acid sequences. The tree is labeled with the vertebrate and fruit fly IDS. A genetic distance scale is shown. The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates are shown. Replicate values of .9 or more which are highly significant (values of .9 or more), are shown with 100 bootstrap replicates performed in each case</p></caption><graphic xlink:href="13205_2016_595_Fig6_HTML" id="MO6"/></fig>
</p></sec></sec><sec id="Sec13"><title>Conclusions</title><p id="Par32">The current results indicate that vertebrate <italic>IDS</italic> genes and encoded proteins represent a distinct gene and protein family of <italic>ARS</italic>-like proteins. IDS has a distinct property among human arylsulfatases in being responsible for the lysosomal degradation of the glycoaminoglycans, heparan sulfate and dermatan sulfate, by hydrolysing 2-sulfate groups of the <sc>l</sc>-iduronate 2-sulfate units (Bielicki et al. <xref ref-type="bibr" rid="CR4">1990</xref>). <italic>IDS</italic> is encoded by a single gene among the vertebrate genomes examined and is highly expressed in human brain and other nerve tissues, and contained 9 coding exons on the negative strand of the human genome. Primate genomes contained an <italic>IDS</italic> pseudogene (<italic>IDSP1</italic>) located in a proximal position on the X-chromosome. The promoter region of the human <italic>IDS</italic> gene contained a large CpG island together with at least 5 TFBS, which may contribute to the high level of gene expression in the brain. In addition, 5 microRNA target sites were observed within the extended 3&#x02032;-UTR of the human IDS gene which may be implicated in regulating gene expression during brain development. Predicted secondary and tertiary structures for human IDS showed strong similarities with other ARS-like proteins. Several major structural domains were apparent for mammalian IDS, including the <italic>N</italic>-terminal leader peptide and propeptide regions; the active site (including a calcium binding site), which is responsible for arylsulfatase activity; and five conserved <italic>N</italic>-glycosylation sites. Phylogenetic studies using 15 vertebrate and one invertebrate (<italic>Drosophila melanogaster</italic>) IDS sequences indicated that the <italic>IDS</italic> gene has appeared early in evolution, prior to the appearance of bony fish.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec14"><p>Below is the link to the electronic supplementary material.
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13205_2016_595_MOESM1_ESM.xlsx"><caption><p>Supplementary Table&#x000a0;1s: Percentage Amino Acid Sequence Identities for Human Arylsulfatase Proteins. Amino acid sequences for the human ARS enzymes were derived from the following: IDS (iduronate 2-sulfatase: UNIPROT: P22304); ARSA (arylsulfatase A: UNIPROT P15289); ARSB (arylsulfatase B: UNIPROT: P15848); STS (sterylsulfatase: UNIPROT P08842); ARSK (arylsulfatase K: UNIPROT: Q6UWY0); SGSH (heparan N-sulfatase: UNIPROT: P51688); SULF1 (extracellular Sulfatase 1: UNIPROT: Q8IWU6); SUMF1 (sulfatase modifying factor 1: UNIPROT: Q8NBK3). (XLSX 45&#x000a0;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>IDS</term><def><p id="Par2">Iduronate 2-sulfatase</p></def></def-item><def-item><term>GAG</term><def><p id="Par3">Glycoaminoglycan</p></def></def-item><def-item><term>ARS</term><def><p id="Par4">Arylsulfatase</p></def></def-item><def-item><term>ARSA</term><def><p id="Par5">Arylsulfatase A</p></def></def-item><def-item><term>kbps</term><def><p id="Par6">Kilobase pairs</p></def></def-item><def-item><term>CpG island</term><def><p id="Par7">Multiple C (cytosine)-G (guanine) dinucleotide region</p></def></def-item><def-item><term>miRNA</term><def><p id="Par8">MicroRNA binding region</p></def></def-item><def-item><term>MPS</term><def><p id="Par9">Mucopolysaccharidosis</p></def></def-item><def-item><term>BLAST</term><def><p id="Par10">Basic local alignment search tool</p></def></def-item><def-item><term>BLAT</term><def><p id="Par11">Blast-like alignment tool</p></def></def-item><def-item><term>NCBI</term><def><p id="Par12">National Center for Biotechnology Information</p></def></def-item><def-item><term>SWISS-MODEL</term><def><p id="Par13">Automated protein structure homology-modeling server</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1007/s13205-016-0595-3) contains supplementary material, which is available to authorized users.</p></fn></fn-group><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p id="Par33">The author declares that he has no conflicts of interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anekar</surname><given-names>J</given-names></name><name><surname>Deepa Narayanan</surname><given-names>C</given-names></name><name><surname>Raj</surname><given-names>AC</given-names></name><name><surname>Sandeepa</surname><given-names>NC</given-names></name><name><surname>Nappalli</surname><given-names>D</given-names></name></person-group><article-title>A rare case of mucopolysaccharidosis: Hunter syndrome</article-title><source>J Clin Diagn Res</source><year>2015</year><volume>9</volume><fpage>ZD23-6</fpage></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>M</given-names></name></person-group><article-title>Mucopolysaccharidosis Type II (Hunter Syndrome): clinical picture and treatment</article-title><source>Curr Pharm Biotechnol</source><year>2011</year><volume>12</volume><fpage>861</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.2174/138920111795542714</pub-id><pub-id pub-id-type="pmid">21235446</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beclin</surname><given-names>C</given-names></name><name><surname>Follert</surname><given-names>P</given-names></name><name><surname>Stappers</surname><given-names>E</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Nathalie</surname><given-names>C</given-names></name><name><surname>de Chevigny</surname><given-names>A</given-names></name><name><surname>Magnone</surname><given-names>V</given-names></name><name><surname>Lebrigand</surname><given-names>K</given-names></name><name><surname>Bissels</surname><given-names>U</given-names></name><name><surname>Huylebroeck</surname><given-names>D</given-names></name><name><surname>Bosio</surname><given-names>A</given-names></name><name><surname>Barbry</surname><given-names>P</given-names></name><name><surname>Seuntjens</surname><given-names>E</given-names></name><name><surname>Cremer</surname><given-names>H</given-names></name></person-group><article-title>miR-200 family controls late steps of postnatal forebrain neurogenesis via Zeb2 inhibition</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>35729</fpage><pub-id pub-id-type="doi">10.1038/srep35729</pub-id><pub-id pub-id-type="pmid">27767083</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielicki</surname><given-names>J</given-names></name><name><surname>Freeman</surname><given-names>C</given-names></name><name><surname>Clements</surname><given-names>PR</given-names></name><name><surname>Hopwood</surname><given-names>JJ</given-names></name></person-group><article-title>Human liver iduronate-2-sulfatase. Purification, characterization and catalytic properties</article-title><source>Biochem J</source><year>1990</year><volume>271</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1042/bj2710075</pub-id><pub-id pub-id-type="pmid">2222422</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>CS</given-names></name><name><surname>Clements</surname><given-names>PR</given-names></name><name><surname>Ashby</surname><given-names>SJ</given-names></name><name><surname>Collyer</surname><given-names>CA</given-names></name><name><surname>Harrop</surname><given-names>SJ</given-names></name><name><surname>Hopwood</surname><given-names>JJ</given-names></name><name><surname>Guss</surname><given-names>JM</given-names></name></person-group><article-title>Structure of a human lysosomal sulfatase</article-title><source>Structure</source><year>1997</year><volume>5</volume><fpage>277</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/S0969-2126(97)00185-8</pub-id><pub-id pub-id-type="pmid">9032078</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho</surname><given-names>C</given-names></name><name><surname>Coulouris</surname><given-names>G</given-names></name><name><surname>Avagyan</surname><given-names>V</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Papadopoulos</surname><given-names>J</given-names></name><name><surname>Bealer</surname><given-names>K</given-names></name><name><surname>Madden</surname><given-names>TL</given-names></name></person-group><article-title>BLAST+: architesture and applications</article-title><source>BMC Bioinform</source><year>2009</year><volume>10</volume><fpage>421</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-421</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chistiakov</surname><given-names>DA</given-names></name><name><surname>Kuzenkova</surname><given-names>LM</given-names></name><name><surname>Savost&#x02019;anov</surname><given-names>KV</given-names></name><name><surname>Gevorkyan</surname><given-names>AK</given-names></name><name><surname>Pushkov</surname><given-names>AA</given-names></name><name><surname>Nikitin</surname><given-names>AG</given-names></name><name><surname>Vashakmadze</surname><given-names>ND</given-names></name><name><surname>Zhurkova</surname><given-names>NV</given-names></name><name><surname>Podkletnova</surname><given-names>TV</given-names></name><name><surname>Namazova-Baranova</surname><given-names>LS</given-names></name><name><surname>Baranov</surname><given-names>AA</given-names></name></person-group><article-title>Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene</article-title><source>J Genet Genom</source><year>2014</year><volume>41</volume><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.jgg.2014.01.007</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Ko</surname><given-names>AR</given-names></name><name><surname>Kwak</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Sohn</surname><given-names>YB</given-names></name><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Jin</surname><given-names>DK</given-names></name></person-group><article-title>Effect of systemic high dose enzyme replacement therapy on the improvement of CNS defects in a mouse model of mucopolysaccharidosis type II</article-title><source>Orphanet J Rare Dis</source><year>2015</year><volume>10</volume><fpage>141</fpage><pub-id pub-id-type="doi">10.1186/s13023-015-0356-0</pub-id><pub-id pub-id-type="pmid">26520066</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chruszcz</surname><given-names>M</given-names></name><name><surname>Laidler</surname><given-names>P</given-names></name><name><surname>Monkiewicz</surname><given-names>M</given-names></name><name><surname>Ortlund</surname><given-names>E</given-names></name><name><surname>Lebioda</surname><given-names>L</given-names></name><name><surname>Lewinski</surname><given-names>K</given-names></name></person-group><article-title>Crystal structure of a covalent intermediate of endogenous human arylsulfatase A</article-title><source>J Inorg Biochem</source><year>2003</year><volume>96</volume><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/S0162-0134(03)00176-4</pub-id><pub-id pub-id-type="pmid">12888274</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name></person-group><article-title>MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells</article-title><source>Mol Cells</source><year>2016</year><volume>39</volume><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.14348/molcells.2016.0118</pub-id><pub-id pub-id-type="pmid">27484906</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dereeper</surname><given-names>A</given-names></name><name><surname>Guignon</surname><given-names>V</given-names></name><name><surname>Blanc</surname><given-names>G</given-names></name><name><surname>Audic</surname><given-names>S</given-names></name><name><surname>Buffet</surname><given-names>S</given-names></name><name><surname>Chevenet</surname><given-names>F</given-names></name><name><surname>Dufayard</surname><given-names>JF</given-names></name><name><surname>Guindon</surname><given-names>S</given-names></name><name><surname>Lefort</surname><given-names>V</given-names></name><name><surname>Lescot</surname><given-names>M</given-names></name><name><surname>Claverie</surname><given-names>JM</given-names></name><name><surname>Gascuel</surname><given-names>O</given-names></name></person-group><article-title>Phylogeny.fr: robust phylogenetic analysis for the non-specialist</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><fpage>W465</fpage><lpage>W469</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn180</pub-id><pub-id pub-id-type="pmid">18424797</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusar Poli</surname><given-names>E</given-names></name><name><surname>Zalfa</surname><given-names>C</given-names></name><name><surname>D&#x02019;Avanzo</surname><given-names>F</given-names></name><name><surname>Tomanin</surname><given-names>R</given-names></name><name><surname>Carlessi</surname><given-names>L</given-names></name><name><surname>Bossi</surname><given-names>M</given-names></name><name><surname>Nodari</surname><given-names>LR</given-names></name><name><surname>Binda</surname><given-names>E</given-names></name><name><surname>Marmiroli</surname><given-names>P</given-names></name><name><surname>Scarpa</surname><given-names>M</given-names></name><name><surname>Delia</surname><given-names>D</given-names></name><name><surname>Vescovi</surname><given-names>AL</given-names></name><name><surname>De Filippis</surname><given-names>L</given-names></name></person-group><article-title>Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><fpage>e906</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.430</pub-id><pub-id pub-id-type="pmid">24201805</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>AR</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Lamsa</surname><given-names>JC</given-names></name><name><surname>Muenzer</surname><given-names>J</given-names></name></person-group><article-title>The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome)</article-title><source>J Inherit Metab Dis</source><year>2007</year><volume>30</volume><fpage>924</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1007/s10545-007-0641-8</pub-id><pub-id pub-id-type="pmid">17876721</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GTEx Consortium</collab></person-group><article-title>Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title><source>Science</source><year>2015</year><volume>348</volume><fpage>648</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1126/science.1262110</pub-id><pub-id pub-id-type="pmid">25954001</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Guzman</surname><given-names>FG</given-names></name><name><surname>Higashiyama</surname><given-names>T</given-names></name><name><surname>Pangborn</surname><given-names>W</given-names></name><name><surname>Osawa</surname><given-names>Y</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name></person-group><article-title>Structure of human estrone sulfatase suggests functional roles of membrane association</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>22989</fpage><lpage>22997</lpage><pub-id pub-id-type="doi">10.1074/jbc.M211497200</pub-id><pub-id pub-id-type="pmid">12657638</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>RS</given-names></name></person-group><article-title>Comparative and evolutionary studies of vertebrate arylsulfatase B, arylsulfatase I and arylsulfatase J genes and proteins: evidence for an ARSB-like sub-family</article-title><source>J Prot Bioinform</source><year>2016</year><volume>9</volume><fpage>11</fpage></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornbeck</surname><given-names>PV</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Murray</surname><given-names>B</given-names></name><name><surname>Kornhauser</surname><given-names>JM</given-names></name><name><surname>Latham</surname><given-names>V</given-names></name><name><surname>Skrzypek</surname><given-names>E</given-names></name></person-group><article-title>PhosphoSitePlus, 2014: mutations, PTMs and recalibrations</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>D512</fpage><lpage>D520</lpage><pub-id pub-id-type="doi">10.1093/nar/gku1267</pub-id><pub-id pub-id-type="pmid">25514926</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Sugnet</surname><given-names>CW</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Roskin</surname><given-names>KM</given-names></name><name><surname>Pringle</surname><given-names>TH</given-names></name><name><surname>Zahler</surname><given-names>AM</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name></person-group><article-title>The human genome browser at UCSC</article-title><source>Genome Res</source><year>2002</year><volume>12</volume><fpage>994</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1101/gr.229202</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosuga</surname><given-names>M</given-names></name><name><surname>Mashima</surname><given-names>R</given-names></name><name><surname>Hirakiyama</surname><given-names>A</given-names></name><name><surname>Fuji</surname><given-names>N</given-names></name><name><surname>Kumagai</surname><given-names>T</given-names></name><name><surname>Seo</surname><given-names>JH</given-names></name><name><surname>Nikaido</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>K</given-names></name><name><surname>Sakuraba</surname><given-names>H</given-names></name><name><surname>Okuyama</surname><given-names>T</given-names></name></person-group><article-title>Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: genetic, pathological, and structural studies on iduronate-2-sulfatase</article-title><source>Mol Genet Metab</source><year>2016</year><volume>118</volume><fpage>190</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2016.05.003</pub-id><pub-id pub-id-type="pmid">27246110</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lv</surname><given-names>X</given-names></name><name><surname>Zhai</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Lou</surname><given-names>J</given-names></name></person-group><article-title>MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson&#x02019;s disease model by targeting Bax and Sirt2</article-title><source>Am J Transl Res</source><year>2016</year><volume>8</volume><fpage>993</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">27158385</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukatela</surname><given-names>G</given-names></name><name><surname>Krauss</surname><given-names>N</given-names></name><name><surname>Theis</surname><given-names>K</given-names></name><name><surname>Selmer</surname><given-names>T</given-names></name><name><surname>Gieselmann</surname><given-names>V</given-names></name><name><surname>von Figura</surname><given-names>K</given-names></name><name><surname>Saenger</surname><given-names>W</given-names></name></person-group><article-title>Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis</article-title><source>Biochemistry</source><year>1998</year><volume>37</volume><fpage>3654</fpage><lpage>3664</lpage><pub-id pub-id-type="doi">10.1021/bi9714924</pub-id><pub-id pub-id-type="pmid">9521684</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchler-Bauer</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>JB</given-names></name><name><surname>Chitsaz</surname><given-names>F</given-names></name><name><surname>Derbyshire</surname><given-names>MK</given-names></name><name><surname>DeWeese-Scott</surname><given-names>C</given-names></name><name><surname>Fong</surname><given-names>JH</given-names></name><name><surname>Geer</surname><given-names>LY</given-names></name><name><surname>Geer</surname><given-names>RC</given-names></name><name><surname>Gonzales</surname><given-names>NR</given-names></name><name><surname>Gwadz</surname><given-names>M</given-names></name><name><surname>Hurwitz</surname><given-names>DI</given-names></name><name><surname>Jackson</surname><given-names>JD</given-names></name><name><surname>Ke</surname><given-names>Z</given-names></name><name><surname>Lanczycki</surname><given-names>CJ</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Marchler</surname><given-names>GH</given-names></name><name><surname>Mullokandov</surname><given-names>M</given-names></name><name><surname>Omelchenko</surname><given-names>MV</given-names></name><name><surname>Robertson</surname><given-names>CL</given-names></name><name><surname>Song</surname><given-names>JS</given-names></name><name><surname>Thanki</surname><given-names>N</given-names></name><name><surname>Yamashita</surname><given-names>RA</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Zheng</surname><given-names>C</given-names></name><name><surname>Bryant</surname><given-names>SH</given-names></name></person-group><article-title>CDD: a conserved domain database for the functional annotation of proteins</article-title><source>Nucleic Acid Res</source><year>2011</year><volume>39</volume><fpage>D225</fpage><lpage>D229</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1189</pub-id><pub-id pub-id-type="pmid">21109532</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>G</given-names></name><name><surname>Vidal</surname><given-names>RL</given-names></name><name><surname>Mardones</surname><given-names>P</given-names></name><name><surname>Serrano</surname><given-names>FG</given-names></name><name><surname>Ardiles</surname><given-names>AO</given-names></name><name><surname>Wirth</surname><given-names>C</given-names></name><name><surname>Vald&#x000e9;s</surname><given-names>P</given-names></name><name><surname>Thielen</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>BL</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Vald&#x000e9;s</surname><given-names>JL</given-names></name><name><surname>Palacios</surname><given-names>AG</given-names></name><name><surname>Inestrosa</surname><given-names>NC</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name><name><surname>Hetz</surname><given-names>C</given-names></name></person-group><article-title>Regulation of memory formation by the transcription factor XBP1</article-title><source>Cell Rep</source><year>2016</year><volume>14</volume><fpage>1382</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.01.028</pub-id><pub-id pub-id-type="pmid">26854229</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>E</given-names></name><name><surname>Tomanin</surname><given-names>R</given-names></name><name><surname>Friso</surname><given-names>A</given-names></name><name><surname>Modena</surname><given-names>N</given-names></name><name><surname>Tiso</surname><given-names>N</given-names></name><name><surname>Scarpa</surname><given-names>M</given-names></name><name><surname>Argenton</surname><given-names>F</given-names></name></person-group><article-title>A novel functional role of iduronate-2-sulfatase in zebrafish early development</article-title><source>Matrix Biol</source><year>2010</year><volume>29</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2009.09.001</pub-id><pub-id pub-id-type="pmid">19761845</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muenzer</surname><given-names>J</given-names></name><name><surname>Hendriksz</surname><given-names>CJ</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name><name><surname>Vijayaraghavan</surname><given-names>S</given-names></name><name><surname>Perry</surname><given-names>V</given-names></name><name><surname>Santra</surname><given-names>S</given-names></name><name><surname>Solanki</surname><given-names>GA</given-names></name><name><surname>Mascelli</surname><given-names>MA</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Sciarappa</surname><given-names>K</given-names></name><name><surname>Barbier</surname><given-names>AJ</given-names></name></person-group><article-title>A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II</article-title><source>Genet Med</source><year>2016</year><volume>18</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/gim.2015.36</pub-id><pub-id pub-id-type="pmid">25834948</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>R</given-names></name><name><surname>Tiwari</surname><given-names>PC</given-names></name><name><surname>Nath</surname><given-names>R</given-names></name><name><surname>Pant</surname><given-names>KK</given-names></name></person-group><article-title>Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson&#x02019;s disease</article-title><source>Neurol Res</source><year>2016</year><volume>3</volume><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parini</surname><given-names>R</given-names></name><name><surname>Rigoldi</surname><given-names>M</given-names></name><name><surname>Tedesco</surname><given-names>L</given-names></name><name><surname>Boffi</surname><given-names>L</given-names></name><name><surname>Brambilla</surname><given-names>A</given-names></name><name><surname>Bertoletti</surname><given-names>S</given-names></name><name><surname>Boncimino</surname><given-names>A</given-names></name><name><surname>Del Longo</surname><given-names>A</given-names></name><name><surname>De Lorenzo</surname><given-names>P</given-names></name><name><surname>Gaini</surname><given-names>R</given-names></name><name><surname>Gallone</surname><given-names>D</given-names></name><name><surname>Gasperini</surname><given-names>S</given-names></name><name><surname>Giussani</surname><given-names>C</given-names></name><name><surname>Grimaldi</surname><given-names>M</given-names></name><name><surname>Grioni</surname><given-names>D</given-names></name><name><surname>Meregalli</surname><given-names>P</given-names></name><name><surname>Messinesi</surname><given-names>G</given-names></name><name><surname>Nichelli</surname><given-names>F</given-names></name><name><surname>Romagnoli</surname><given-names>M</given-names></name><name><surname>Russo</surname><given-names>P</given-names></name><name><surname>Sganzerla</surname><given-names>E</given-names></name><name><surname>Valsecchi</surname><given-names>G</given-names></name><name><surname>Biondi</surname><given-names>A</given-names></name></person-group><article-title>Enzymatic replacement therapy for Hunter disease: up to 9&#x000a0;years experience with 17 patients</article-title><source>Mol Genet Metab Rep</source><year>2015</year><volume>3</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.ymgmr.2015.03.011</pub-id><pub-id pub-id-type="pmid">26937399</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathmann</surname><given-names>M</given-names></name><name><surname>Bunge</surname><given-names>S</given-names></name><name><surname>Beck</surname><given-names>M</given-names></name><name><surname>Kresse</surname><given-names>H</given-names></name><name><surname>Tylki-Szymanska</surname><given-names>A</given-names></name><name><surname>Gal</surname><given-names>A</given-names></name></person-group><article-title>Mucopolysaccharidosis type II (Hunter syndrome): mutation &#x0201c;hot spots&#x0201d; in the iduronate-2-sulfatase gene</article-title><source>Am J Hum Genet</source><year>1996</year><volume>59</volume><fpage>1202</fpage><lpage>1209</lpage><pub-id pub-id-type="pmid">8940265</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratzka</surname><given-names>A</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Vortkamp</surname><given-names>A</given-names></name></person-group><article-title>Expression patterns of sulfatase genes in the developing mouse embryo</article-title><source>Dev Dyn</source><year>2010</year><volume>239</volume><fpage>1779</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22294</pub-id><pub-id pub-id-type="pmid">20503373</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Col&#x000f3;n</surname><given-names>Y</given-names></name><name><surname>Schutsky</surname><given-names>EK</given-names></name><name><surname>Kita</surname><given-names>AZ</given-names></name><name><surname>Garman</surname><given-names>SC</given-names></name></person-group><article-title>The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A</article-title><source>J Mol Biol</source><year>2012</year><volume>423</volume><fpage>736</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2012.08.020</pub-id><pub-id pub-id-type="pmid">22940367</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;enz</surname><given-names>H</given-names></name><name><surname>Lareo</surname><given-names>L</given-names></name><name><surname>Poutou</surname><given-names>RA</given-names></name><name><surname>Sosa</surname><given-names>AC</given-names></name><name><surname>Barrera</surname><given-names>LA</given-names></name></person-group><article-title>Computational prediction of the tertiary structure of the human iduronate 2-sulfate sulfatase</article-title><source>Biomedica</source><year>2007</year><volume>27</volume><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.7705/biomedica.v27i1.229</pub-id><pub-id pub-id-type="pmid">17546220</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname><given-names>M</given-names></name><name><surname>Annunziata</surname><given-names>I</given-names></name><name><surname>Roma</surname><given-names>G</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name></person-group><article-title>Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3203</fpage><lpage>3217</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi351</pub-id><pub-id pub-id-type="pmid">16174644</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxonov</surname><given-names>S</given-names></name><name><surname>Berg</surname><given-names>P</given-names></name><name><surname>Brutlag</surname><given-names>DL</given-names></name></person-group><article-title>A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>1412</fpage><lpage>1417</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510310103</pub-id><pub-id pub-id-type="pmid">16432200</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwede</surname><given-names>T</given-names></name><name><surname>Kopp</surname><given-names>J</given-names></name><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Pietsch</surname><given-names>MC</given-names></name></person-group><article-title>SWISS-MODEL: an automated protein homology-modelling server</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>3381</fpage><lpage>3385</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg520</pub-id><pub-id pub-id-type="pmid">12824332</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>KS</given-names></name><name><surname>Rosner</surname><given-names>M</given-names></name><name><surname>Freilinger</surname><given-names>A</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><name><surname>Hengstschl&#x000e4;ger</surname><given-names>M</given-names></name></person-group><article-title>Bach2 is involved in neuronal differentiation of N1E&#x02212;115 neuroblastoma cells</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><fpage>2264</fpage><lpage>2278</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.03.018</pub-id><pub-id pub-id-type="pmid">16631738</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sievers</surname><given-names>F</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name></person-group><article-title>Clustal omega</article-title><source>Curr Protoc Bioinform</source><year>2014</year><volume>2014</volume><issue>48</issue><fpage>1</fpage><lpage>16</lpage></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CM</given-names></name><name><surname>Finger</surname><given-names>JH</given-names></name><name><surname>Hayamizu</surname><given-names>TF</given-names></name><name><surname>McCright</surname><given-names>IJ</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Berghout</surname><given-names>J</given-names></name><name><surname>Campbell</surname><given-names>J</given-names></name><name><surname>Corbani</surname><given-names>LE</given-names></name><name><surname>Forthofer</surname><given-names>KL</given-names></name><name><surname>Frost</surname><given-names>PJ</given-names></name><name><surname>Miers</surname><given-names>D</given-names></name><name><surname>Shaw</surname><given-names>DR</given-names></name><name><surname>Stone</surname><given-names>KR</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Kadin</surname><given-names>JA</given-names></name><name><surname>Richardson</surname><given-names>JE</given-names></name><name><surname>Ringwald</surname><given-names>M</given-names></name></person-group><article-title>The mouse gene expression database (GXD): 2014 update</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><issue>D1</issue><fpage>D818</fpage><lpage>D824</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt954</pub-id><pub-id pub-id-type="pmid">24163257</pub-id></element-citation></ref><ref id="CR38"><mixed-citation publication-type="other">Thierry-Mieg D, Thierry-Mieg J (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol. 7(Suppl 1) S12:1-14</mixed-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tylki-Szyma&#x00144;ska</surname><given-names>A</given-names></name></person-group><article-title>Mucopolysaccharidosis type II, Hunter&#x02019;s syndrome</article-title><source>Pediatr Endocrinol Rev</source><year>2014</year><volume>12</volume><issue>Suppl 1</issue><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">25345092</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vafiadaki</surname><given-names>E</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Heptinstall</surname><given-names>LE</given-names></name><name><surname>Hatton</surname><given-names>CE</given-names></name><name><surname>Thornley</surname><given-names>M</given-names></name><name><surname>Wraith</surname><given-names>JE</given-names></name></person-group><article-title>Mutation analysis in 57 unrelated patients with MPS II (Hunter&#x02019;s disease)</article-title><source>Arch Dis Child</source><year>1998</year><volume>79</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1136/adc.79.3.237</pub-id><pub-id pub-id-type="pmid">9875019</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>LM</given-names></name><name><surname>Timme-Laragy</surname><given-names>AR</given-names></name><name><surname>Goldstone</surname><given-names>JV</given-names></name><name><surname>McArthur</surname><given-names>AG</given-names></name><name><surname>Stegeman</surname><given-names>JJ</given-names></name><name><surname>Smolowitz</surname><given-names>RM</given-names></name><name><surname>Hahn</surname><given-names>ME</given-names></name></person-group><article-title>Developmental expression of the Nfe2-related factor (Nrf) transcription factor family in the zebrafish, Danio rerio</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e79574</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0079574</pub-id><pub-id pub-id-type="pmid">24298298</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>PJ</given-names></name><name><surname>Morris</surname><given-names>CP</given-names></name><name><surname>Anson</surname><given-names>DS</given-names></name><name><surname>Occhiodoro</surname><given-names>T</given-names></name><name><surname>Bielicki</surname><given-names>J</given-names></name><name><surname>Clements</surname><given-names>PR</given-names></name><name><surname>Hopwood</surname><given-names>JJ</given-names></name></person-group><article-title>Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA</article-title><source>Proc Natl Acad Sci USA</source><year>1990</year><volume>87</volume><fpage>8531</fpage><lpage>8535</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.21.8531</pub-id><pub-id pub-id-type="pmid">2122463</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>PJ</given-names></name><name><surname>Meaney</surname><given-names>CA</given-names></name><name><surname>Hopwood</surname><given-names>JJ</given-names></name><name><surname>Morris</surname><given-names>CP</given-names></name></person-group><article-title>Sequence of the human iduronate 2-sulfatase (IDS) gene</article-title><source>Genomics</source><year>1993</year><volume>17</volume><issue>3</issue><fpage>773</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1006/geno.1993.1406</pub-id><pub-id pub-id-type="pmid">8244397</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>XY</given-names></name><name><surname>Zhang</surname><given-names>LY</given-names></name></person-group><article-title>MicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis</article-title><source>J Clin Neurosci</source><year>2015</year><volume>22</volume><fpage>1254</fpage><lpage>1257</lpage><pub-id pub-id-type="doi">10.1016/j.jocn.2015.01.031</pub-id><pub-id pub-id-type="pmid">25882257</pub-id></element-citation></ref></ref-list></back></article>